ARCHIVES

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

AACI, SCO, ACCC Hold Meeting With HCFA On DRG Issue

June 17, 1983

AACR, ASCO Publish Reports Examining U.S. Cancer Care

April 4, 2014

News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions

April 27, 2012

USC Scientists Says It’s Time Nobelists Recognize Value of Cancer Program

February 10, 1978

More Oncopathology Research Asked

June 30, 1978

Funding Opportunities Listed (12-page issue).

July 11, 2003